Immediate Impact
69 standout
Citing Papers
Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release
2024 Standout
Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522
2024 Standout
Works of Brooke Daniel being referenced
Panitumumab, Gemcitabine, and Carboplatin as Treatment for Women With Metastatic Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial
2016
A Phase II Trial of Dose-Dense Neoadjuvant Gemcitabine, Epirubicin, and Albumin-Bound Paclitaxel With Pegfilgrastim in the Treatment of Patients With Locally Advanced Breast Cancer
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Brooke Daniel | 164 | 57 | 66 | 17 | 188 | |
| Aurélie Maran-Gonzalez | 159 | 117 | 82 | 16 | 249 | |
| Peter Schmid | 191 | 45 | 105 | 11 | 224 | |
| Sylvain Dureau | 111 | 67 | 47 | 19 | 203 | |
| Wichit Arpornwirat | 171 | 56 | 69 | 17 | 274 | |
| Coralia Bueno | 108 | 62 | 75 | 21 | 163 | |
| T. Valdez | 234 | 61 | 141 | 16 | 275 | |
| Ignacio Tusquets | 128 | 58 | 109 | 16 | 248 | |
| A. Stopeck | 236 | 86 | 80 | 20 | 287 | |
| Shailesh Bondarde | 148 | 52 | 69 | 22 | 223 | |
| G Moro | 110 | 60 | 43 | 15 | 188 |
All Works
Loading papers...